← Leaderboards
Yanfen Hu
University Of Virginia
$4,571,345
Attributed
$8,594,732
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,594,732 · 8
By mechanism
R01$7,459,001 · 5
R21$1,135,731 · 3
Top collaborators
- Rong Li17 shared
- Tyler J. Curiel2 shared
- Nu Zhang2 shared
Most similar at University Of Virginia
Same institution · by research overlap
- James M Larner$8,820,863
- Tarek A. Abbas$2,785,225
- Benjamin W. Purow$10,419,575
- Kazlin Mason$625,813
- Daniel Abebayehu$2,890,236
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMalignant NeoplasmsCellsMalignant Breast NeoplasmResponsePositioning AttributeTumor Suppressor ProteinsBaseBrca1 GeneDna RepairIn VivoMammary NeoplasmsGenesStromal CellsGenetic TranscriptionBrca1 MutationMouse ModelTissuesPlayNeoplastic CellExperimental StudyMammary Gland ParenchymaTranscriptional RegulationDna Double Strand Break
Grant awards (25)
Adipocyte PD-L1 in the Breast Tumor Microenvironment$660,030
R01 · FY2025 · CA
A Novel Regulator of Antitumor Immunity and Immunotherapy$656,704
R01 · FY2025 · CA
T Cell-Specific BRCA1 Function in Antitumor Immunity and Immunotherapy$614,606
R01 · FY2025 · CA
Adipocyte PD-L1 in the Breast Tumor Microenvironment$675,405
R01 · FY2024 · CA
A Novel Regulator of Antitumor Immunity and Immunotherapy$669,506
R01 · FY2024 · CA
T Cell-Specific BRCA1 Function in Antitumor Immunity and Immunotherapy$583,876
R01 · FY2024 · CA
T Cell-Specific BRCA1 Function in Antitumor Immunity and Immunotherapy$614,606
R01 · FY2023 · CA
Role of BRCA1 phosphorylation in DNA DSB repair and genome stability maintenance$383,536
R01 · FY2022 · CA · contact PI
Role of BRCA1 phosphorylation in DNA DSB repair and genome stability maintenance$391,364
R01 · FY2021 · CA · contact PI
Role of BRCA1 phosphorylation in DNA DSB repair and genome stability maintenance$1
R01 · FY2020 · CA · contact PI
Role of BRCA1 phosphorylation in DNA DSB repair and genome stability maintenance$379,621
R01 · FY2019 · CA · contact PI
Role of BRCA1 phosphorylation in DNA DSB repair and genome stability maintenance$374,188
R01 · FY2018 · CA · contact PI
A Dual Functional Switch in Reproductive Biology$199,375
R21 · FY2018 · HD
Role of BRCA1 phosphorylation in DNA DSB repair and genome stability maintenance$374,188
R01 · FY2017 · CA · contact PI
A Dual Functional Switch in Reproductive Biology$228,750
R21 · FY2017 · HD
(PQA-2) Reprogramming of circulating adipose stromal cells by mechanical stress$160,643
R21 · FY2015 · CA
FBX044 mediated BRCA1 degradation in sporadic breast cancers$160,643
R21 · FY2015 · CA · contact PI
FBX044 mediated BRCA1 degradation in sporadic breast cancers$193,160
R21 · FY2014 · CA · contact PI
(PQA-2) Reprogramming of circulating adipose stromal cells by mechanical stress$193,160
R21 · FY2014 · CA
The Mechanism of BRCA1 in Tumor Suppression$201,308
R01 · FY2010 · CA · contact PI
The Mechanism of BRCA1 in Tumor Suppression$245,846
R01 · FY2009 · CA · contact PI
The Mechanism of BRCA1 in Tumor Suppression$201,308
R01 · FY2008 · CA · contact PI
The Mechanism of BRCA1 in Tumor Suppression$201,308
R01 · FY2007 · CA · contact PI
The Mechanism of BRCA1 in Tumor Suppression$146,000
R01 · FY2006 · CA · contact PI
The Mechanism of BRCA1 in Tumor Suppression$85,600
R01 · FY2006 · CA · contact PI